Biomarin Pharmaceuticals
(BMRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 437,446 | 493,982 | 598,028 | 408,330 | 397,040 |
| Marketable Securities | 316,361 | 590,326 | 797,940 | 381,347 | 195,579 |
| Receivables | 377,404 | 342,633 | 261,365 | 215,280 | 164,959 |
| Inventories | 680,275 | 530,871 | 475,775 | 355,126 | 271,683 |
| Other current assets | 130,657 | 98,403 | 74,036 | 61,708 | 60,378 |
| TOTAL | $1,942,143 | $2,056,215 | $2,207,144 | $1,421,791 | $1,089,639 |
| Non-Current Assets | |||||
| PPE Net | 1,010,868 | 948,682 | 896,700 | 798,768 | 704,207 |
| Investments And Advances | 411,978 | 235,864 | 385,785 | 572,711 | 425,652 |
| Intangibles | 653,619 | 688,847 | 714,549 | 750,819 | 881,035 |
| Other Non-Current Assets | 671,431 | 497,520 | 428,947 | 479,601 | 628,835 |
| TOTAL | $2,747,896 | $2,370,913 | $2,425,981 | $2,601,899 | $2,639,729 |
| Total Assets | $4,690,039 | $4,427,128 | $4,633,125 | $4,023,690 | $3,729,368 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 361,882 | N/A | 360,949 | 22,478 | N/A |
| Accounts payable and accrued liabilities | 570,621 | 523,241 | 455,569 | 416,832 | 445,457 |
| TOTAL | $932,503 | $523,241 | $816,518 | $439,310 | $445,457 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 635,155 | 935,947 | 1,007,944 | 818,105 | 739,537 |
| TOTAL | $635,155 | $935,947 | $1,007,944 | $818,105 | $883,064 |
| Total Liabilities | $1,567,658 | $1,459,188 | $1,824,462 | $1,257,415 | $1,328,521 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 179,926 | 178,372 | 176,072 | 172,867 | 161,591 |
| Common Shares | 180 | 178 | 176 | 173 | 162 |
| Retained earnings | -1,720,709 | -1,694,134 | -1,637,548 | -1,520,506 | -1,021,569 |
| Other shareholders' equity | 10,203 | -8,030 | -37,185 | -1,505 | 7,417 |
| TOTAL | $3,122,381 | $2,967,940 | $2,808,663 | $2,766,275 | $2,400,847 |
| Total Liabilities And Equity | $4,690,039 | $4,427,128 | $4,633,125 | $4,023,690 | $3,729,368 |